Research has shown that co-processing raw bio-oil is challenging but it can be carried out after adoption of appropriate reactor modifications in the commercial scale.

Research has shown that co-processing raw bio-oil is challenging but it can be carried out after adoption of appropriate reactor modifications in the commercial scale.
To make photogalvanic cells a reality in life for simultaneous solar power and storage, some challenges have to be tackled
Nanostructured hydroxyapatite (nHAp) appears to have a great potential to revolutionize the hard tissue-engineering field, starting from bone repair and augmentation to controlled drug delivery systems.
Genome-editing therapeutics introduce foreign nucleic acids and proteins into the circulation and cells, which can activate the innate, cellular, and humoral immunity in human patients. The key obstacle in translating CRISPR therapeutics to the clinic is hence to identify, diminish, and monitor these immunological risks before adverse immune reactions.
Internal ribosome entry sites (IRES) are used by some viruses to hijack the host cellular translation machinery for their own translation.
Pattern regulation, as observed in regeneration and development, enables cells to cooperate toward the creation and maintenance of complex anatomies. This image shows planaria, of which every piece has the information needed to restore a complete planarian target morphology.
In contrast to healthy tissue, tumors demand a high supply of nutrients and oxygen, and will invade existing vessels and develop new ones to meet these demands.
The RNA-binding protein vigilin is conserved from yeasts to humans. Through 30 years of study, vigilin has been associated with a variety of cellular functions both in the nucleus and in the cytoplasm.
Non-coding RNA expression varies at the single cell level, at least as much variability as protein-coding RNA, and some classes of non-coding RNA may display more single cell variability.
RNA-binding proteins influence epithelial ovarian cancer progression through complex networks with mRNAs, non-coding RNAs and other proteins.